🟢 NanoViricides is trading 6% up in pre-market with no identified catalyst

NanoViricides is trading at $1.48, up 5.71% in pre-market, with no company-specific catalyst identified.

• The latest reported company news was an October 20 update on juvenile-mouse safety results for NV-387, predating this session.
• NanoViricides’ investor information lists an October 16 Ebola-trial enrollment update, but no October 26 catalyst was listed.
• Market indexes were mixed, so a broader-market explanation is not established; no volume or activity data was provided.